Glucocorticoid treatment in juvenile idiopathic arthritis
Sign Up to like & getrecommendations! Published in 2018 at "Rheumatology International"
DOI: 10.1007/s00296-018-4168-0
Abstract: Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease of joints in childhood. Glucocorticoids are being used in JIA treatment effectively for decades. Although systemic glucocorticoid use decreased with the introduction of biologic… read more here.
Keywords: juvenile idiopathic; use; jia; treatment ... See more keywords
Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registry
Sign Up to like & getrecommendations! Published in 2021 at "Rheumatology International"
DOI: 10.1007/s00296-020-04774-3
Abstract: To examine whether treatment with interleukin (IL)-1-, IL-6-, tumour necrosis factor α (TNFα)-inhibitors or Abatacept is associated with an increased risk of common infections, infections requiring hospitalization (SAE) or opportunistic infections among real-world juvenile idiopathic… read more here.
Keywords: real world; risk; juvenile idiopathic; jia ... See more keywords
Hepatitis B vaccination response of treatment-naive patients with juvenile idiopathic arthritis
Sign Up to like & getrecommendations! Published in 2021 at "Rheumatology International"
DOI: 10.1007/s00296-021-04833-3
Abstract: To evaluate the vaccine response of treatment-naive juvenile idiopathic arthritis (JIA) patients who were fully vaccinated against Hepatitis B Virus (HBV) and then compare their antibody status with healthy controls. In this multicenter study, initial… read more here.
Keywords: jia; hepatitis; anti hbs; rheumatology ... See more keywords
Imaging assessment of children presenting with suspected or known juvenile idiopathic arthritis: ESSR-ESPR points to consider
Sign Up to like & getrecommendations! Published in 2020 at "European Radiology"
DOI: 10.1007/s00330-020-06807-8
Abstract: Abstract Juvenile idiopathic arthritis (JIA) is the most common paediatric rheumatic disease. It represents a group of heterogenous inflammatory disorders with unknown origin and is a diagnosis of exclusion in which imaging plays an important… read more here.
Keywords: juvenile idiopathic; jia; essr; idiopathic arthritis ... See more keywords
The profile of polyunsaturated fatty acids in juvenile idiopathic arthritis and association with disease activity
Sign Up to like & getrecommendations! Published in 2017 at "Clinical Rheumatology"
DOI: 10.1007/s10067-017-3586-9
Abstract: We investigated the association between dietary intake of n-3 and n-6 polyunsaturated fatty acids (PUFAs), serum profiles, and immune and inflammatory markers in juvenile idiopathic arthritis (JIA) in relation to onset, activity, and duration. A… read more here.
Keywords: juvenile idiopathic; polyunsaturated fatty; jia; fatty acids ... See more keywords
Association of interferon regulatory factor 5 (IRF5) gene polymorphisms with juvenile idiopathic arthritis
Sign Up to like & getrecommendations! Published in 2018 at "Clinical Rheumatology"
DOI: 10.1007/s10067-018-4010-9
Abstract: Interferon regulatory factor 5 (IRF5) is a member of IRF family which induce signaling pathways and are involved in modulation of cell growth, differentiation, apoptosis, and immune system activity. Juvenile idiopathic arthritis (JIA) is an… read more here.
Keywords: irf5; jia; factor irf5; interferon regulatory ... See more keywords
Evaluation of plasma microRNA expressions in patients with juvenile idiopathic arthritis
Sign Up to like & getrecommendations! Published in 2018 at "Clinical Rheumatology"
DOI: 10.1007/s10067-018-4277-x
Abstract: Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease of childhood, yet its etiology is unknown. It is known that microribonucleic acids (miRNAs) play a role in immunoregulation. We aimed to evaluate the… read more here.
Keywords: juvenile idiopathic; plasma; jia; idiopathic arthritis ... See more keywords
The frequency of infections in patients with juvenile idiopathic arthritis on biologic agents: 1-year prospective study
Sign Up to like & getrecommendations! Published in 2018 at "Clinical Rheumatology"
DOI: 10.1007/s10067-018-4367-9
Abstract: IntroductionThe most effective and concurrently the safest treatment regimen selection is important to provide early control of juvenile idiopathic arthritis (JIA) and to have an acceptable quality of life. The effectivity of biologic agents as… read more here.
Keywords: jia; infection; year; study ... See more keywords
Magnetic resonance imaging findings in the sternoclavicular joint in juvenile idiopathic arthritis and comparison with clinical examination
Sign Up to like & getrecommendations! Published in 2021 at "Clinical Rheumatology"
DOI: 10.1007/s10067-020-05525-2
Abstract: Objective The sternoclavicular joint (SCJ), an important link between the appendicular and axial skeleton, though involved in 41% of rheumatoid arthritis patients, has not been studied in juvenile idiopathic arthritis (JIA). Hence, this cross-sectional study… read more here.
Keywords: jia; sternoclavicular joint; clinical examination; rheumatology ... See more keywords
Juvenile idiopathic arthritis-associated uveitis.
Sign Up to like & getrecommendations! Published in 2019 at "Clinical immunology"
DOI: 10.1016/j.clim.2019.108322
Abstract: Juvenile idiopathic arthritis (JIA) is the commonest rheumatic disease in children and JIA-associated uveitis its most frequent extra-articular manifestation. The uveitis is potentially sight-threatening and so carries a considerable risk of morbidity. The commonest form… read more here.
Keywords: juvenile idiopathic; associated uveitis; idiopathic arthritis; jia ... See more keywords
Soluble CD163, a unique biomarker to evaluate the disease activity, exhibits macrophage activation in systemic juvenile idiopathic arthritis
Sign Up to like & getrecommendations! Published in 2018 at "Cytokine"
DOI: 10.1016/j.cyto.2018.05.017
Abstract: HighlightsSerum sCD163 levels correlated positively with the disease activity of s‐JIA, even in patients receiving tocilizumab.Serum sCD163 level is a potential diagnostic laboratory criterion for clinical remission in patients with s‐JIA.Serum sCD163 levels profoundly increased… read more here.
Keywords: scd163; jia; disease activity; scd163 levels ... See more keywords